HomeCompareJNJ vs AXP

JNJ vs AXP: Dividend Comparison 2026

JNJ yields 2.14% · AXP yields 1.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AXP wins by $430.9K in total portfolio value
10 years
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →
AXP
AXP
● Live price
1.10%
Share price
$297.58
Annual div
$3.28
5Y div CAGR
78.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$461.4K
Annual income
$298,922.75
Full AXP calculator →

Portfolio growth — JNJ vs AXP

📍 AXP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJNJAXP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JNJ + AXP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JNJ pays
AXP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
AXP
Annual income on $10K today (after 15% tax)
$93.69/yr
After 10yr DRIP, annual income (after tax)
$254,084.34/yr
At 15% tax rate, AXP beats the other by $250,046.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JNJ + AXP for your $10,000?

JNJ: 50%AXP: 50%
100% AXP50/50100% JNJ
Portfolio after 10yr
$245.9K
Annual income
$151,836.31/yr
Blended yield
61.74%
📊

Analyst Conviction Gap

Where Wall Street is split right now

JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
AXP
Analyst Ratings
21
Buy
32
Hold
4
Sell
Consensus: Hold
Price Target
$374.58
+25.9% upside vs current
Range: $295.00 — $425.00
Altman Z
0.5
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JNJ buys
8
AXP buys
0
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJNJAXP
Forward yield2.14%1.10%
Annual dividend / share$5.20$3.28
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR28%78.5%
Portfolio after 10y$30.5K$461.4K
Annual income after 10y$4,749.88$298,922.75
Total dividends collected$15.6K$425.9K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusBuyHold
Analyst price target$228.73$374.58

Year-by-year: JNJ vs AXP ($10,000, DRIP)

YearJNJ PortfolioJNJ Income/yrAXP PortfolioAXP Income/yrGap
1← crossover$10,594$274.49$10,897$196.75$303.00AXP
2$11,294$360.69$12,017$357.65$723.00AXP
3$12,133$476.91$13,516$657.99$1.4KAXP
4$13,156$635.42$15,697$1,234.61$2.5KAXP
5$14,432$854.61$19,188$2,391.92$4.8KAXP
6$16,056$1,162.76$25,409$4,877.60$9.4KAXP
7$18,175$1,604.53$37,962$10,774.96$19.8KAXP
8$21,009$2,252.68$67,475$26,855.93$46.5KAXP
9$24,911$3,229.73$151,831$79,632.36$126.9KAXP
10$30,458$4,749.88$461,382$298,922.75$430.9KAXP

JNJ vs AXP: Complete Analysis 2026

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

AXPFinancials

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.

Full AXP Calculator →
📬

Get this JNJ vs AXP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JNJ vs ABBVJNJ vs MRKJNJ vs PFEJNJ vs BMYJNJ vs LLYJNJ vs SCHDJNJ vs JEPIJNJ vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.